- Home
- NXRT vs IRON Comparison
NXRT vs IRON Comparison
Compare NXRT & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXRT
- IRON
- Stock Information
- Founded
- NXRT 2014
- IRON 2017
- Country
- NXRT United States
- IRON United States
- Employees
- NXRT N/A
- IRON N/A
- Industry
- NXRT Real Estate Investment Trusts
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- NXRT Real Estate
- IRON Health Care
- Exchange
- NXRT Nasdaq
- IRON Nasdaq
- Market Cap
- NXRT 1.2B
- IRON 1.4B
- IPO Year
- NXRT N/A
- IRON N/A
- Fundamental
- Price
- NXRT $43.49
- IRON $63.50
- Analyst Decision
- NXRT Buy
- IRON Strong Buy
- Analyst Count
- NXRT 5
- IRON 10
- Target Price
- NXRT $49.00
- IRON $73.70
- AVG Volume (30 Days)
- NXRT 91.8K
- IRON 248.1K
- Earning Date
- NXRT 02-18-2025
- IRON 11-12-2024
- Dividend Yield
- NXRT 4.52%
- IRON N/A
- EPS Growth
- NXRT 54.64
- IRON N/A
- EPS
- NXRT 1.77
- IRON N/A
- Revenue
- NXRT $264,974,000.00
- IRON N/A
- Revenue This Year
- NXRT N/A
- IRON N/A
- Revenue Next Year
- NXRT $0.54
- IRON N/A
- P/E Ratio
- NXRT $25.24
- IRON N/A
- Revenue Growth
- NXRT N/A
- IRON N/A
- 52 Week Low
- NXRT $28.20
- IRON $25.60
- 52 Week High
- NXRT $48.37
- IRON $77.60
- Technical
- Relative Strength Index (RSI)
- NXRT 43.52
- IRON 52.18
- Support Level
- NXRT $44.31
- IRON $62.31
- Resistance Level
- NXRT $46.15
- IRON $67.87
- Average True Range (ATR)
- NXRT 0.90
- IRON 3.04
- MACD
- NXRT -0.30
- IRON -0.48
- Stochastic Oscillator
- NXRT 14.08
- IRON 34.01
About NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.